---
figid: PMC2997588__mt2010188f8
figlink: /pmc/articles/PMC2997588/figure/fig8/
number: F8
caption: A proposed model of VSV-obatoclax synergism. In CLL cells, the proapoptotic
  activity of BAX and BAK are inhibited via association with antiapoptotic BCL-2 and
  MCL-1, respectively. obatoclax15-070 occupies the BH-3-binding groove of prosurvival
  BCL-2 and MCL-1 to disrupt BCL-2/BAX and MCL-1/BAK heterodimers, thus restoring
  the ability of the intrinsic apoptotic pathway to respond to VSV apoptotic stimuli.
  In response to VSV infection, the BH-3-only protein NOXA is induced at the transcriptional
  level, additionally contributing to the abrogation of MCL-1/BAK complexes. Activated
  NOXA protein may also directly induce a conformational change in BAX that subsequently
  promotes translocation to the mitochondria outer membrane. The VSV-obatoclax combination
  therapy leads to the activation and oligomerization of BAX and BAK homo- and heterodimers
  and thus membrane permeabilization, cytochrome c formation of the apoptosome and
  activation of the caspase cascade. BCL, B-cell lymphoma-2; CLL, chronic lymphocytic
  leukemia; MCL, myeloid cell leukemia-1; Obato., obatoclax; VSV, vesicular stomatitis
  virus.
pmcid: PMC2997588
papertitle: VSV Oncolysis in Combination With the BCL-2 Inhibitor Obatoclax Overcomes
  Apoptosis Resistance in Chronic Lymphocytic Leukemia.
reftext: Sara Samuel, et al. Mol Ther. 2010 Dec;18(12):2094-2103.
pmc_ranked_result_index: '160013'
pathway_score: 0.9421819
filename: mt2010188f8.jpg
figtitle: Proposed model of VSV-obatoclax synergism
year: '2010'
organisms: Homo sapiens
ndex: 30d88271-df04-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC2997588__mt2010188f8.html
  '@type': Dataset
  description: A proposed model of VSV-obatoclax synergism. In CLL cells, the proapoptotic
    activity of BAX and BAK are inhibited via association with antiapoptotic BCL-2
    and MCL-1, respectively. obatoclax15-070 occupies the BH-3-binding groove of prosurvival
    BCL-2 and MCL-1 to disrupt BCL-2/BAX and MCL-1/BAK heterodimers, thus restoring
    the ability of the intrinsic apoptotic pathway to respond to VSV apoptotic stimuli.
    In response to VSV infection, the BH-3-only protein NOXA is induced at the transcriptional
    level, additionally contributing to the abrogation of MCL-1/BAK complexes. Activated
    NOXA protein may also directly induce a conformational change in BAX that subsequently
    promotes translocation to the mitochondria outer membrane. The VSV-obatoclax combination
    therapy leads to the activation and oligomerization of BAX and BAK homo- and heterodimers
    and thus membrane permeabilization, cytochrome c formation of the apoptosome and
    activation of the caspase cascade. BCL, B-cell lymphoma-2; CLL, chronic lymphocytic
    leukemia; MCL, myeloid cell leukemia-1; Obato., obatoclax; VSV, vesicular stomatitis
    virus.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CASP2
  - CASP10
  - CASP1
  - CASP14
  - CASP3
  - MCL1
  - IRF3
  - CASP9
  - CASP5
  - CASP12
  - BAX
  - TP53
  - PMAIP1
  - CASP4
  - BCL2
  - BAK1
  - CASP8
  - CASP6
  - CASP7
genes:
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP2
  entrez: '835'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP10
  entrez: '843'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP1
  entrez: '834'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP14
  entrez: '23581'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP3
  entrez: '836'
- word: MCL-1
  symbol: Mcl-1
  source: hgnc_alias_symbol
  hgnc_symbol: MCL1
  entrez: '4170'
- word: IRF-3
  symbol: IRF3
  source: hgnc_symbol
  hgnc_symbol: IRF3
  entrez: '3661'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP9
  entrez: '842'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP5
  entrez: '838'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP12
  entrez: '100506742'
- word: BAX
  symbol: BAX
  source: hgnc_symbol
  hgnc_symbol: BAX
  entrez: '581'
- word: P53
  symbol: p53
  source: hgnc_alias_symbol
  hgnc_symbol: TP53
  entrez: '7157'
- word: NOXA-
  symbol: NOXA
  source: hgnc_alias_symbol
  hgnc_symbol: PMAIP1
  entrez: '5366'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP4
  entrez: '837'
- word: BCL-2
  symbol: Bcl-2
  source: hgnc_alias_symbol
  hgnc_symbol: BCL2
  entrez: '596'
- word: BAK
  symbol: BAK
  source: hgnc_alias_symbol
  hgnc_symbol: BAK1
  entrez: '578'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP8
  entrez: '841'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP6
  entrez: '839'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP7
  entrez: '840'
chemicals: []
diseases: []
figid_alias: PMC2997588__F8
redirect_from: /figures/PMC2997588__F8
figtype: Figure
---
